Solid Biosciences Inc. Quarterly Debt-to-equity in % from Q3 2018 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Solid Biosciences Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q4 2024.
Solid Biosciences Inc. Debt-to-equity for the quarter ending December 31, 2024 was 24.3 %, a 9.37% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	24.3	-2.51	-9.37%	Dec 31, 2024
Q3 2024	22.8	-2.19	-8.77%	Sep 30, 2024
Q2 2024	22.9	-2.24	-8.91%	Jun 30, 2024
Q1 2024	24.5	-1.49	-5.74%	Mar 31, 2024
Q4 2023	26.8	+4.29	+19.1%	Dec 31, 2023
Q3 2023	25	+5.86	+30.7%	Sep 30, 2023
Q2 2023	25.1	+9.98	+65.9%	Jun 30, 2023
Q1 2023	25.9	+14.3	+122%	Mar 31, 2023
Q4 2022	22.5	+10.6	+88.7%	Dec 31, 2022
Q3 2022	19.1	+4.36	+29.5%	Sep 30, 2022
Q2 2022	15.2	-3.07	-16.8%	Jun 30, 2022
Q1 2022	11.7	-12.2	-51.1%	Mar 31, 2022
Q4 2021	11.9	-24.7	-67.5%	Dec 31, 2021
Q3 2021	14.8	-23.6	-61.5%	Sep 30, 2021
Q2 2021	18.2	-9.98	-35.4%	Jun 30, 2021
Q1 2021	23.9	-2	-7.74%	Mar 31, 2021
Q4 2020	36.6	+12.8	+53.8%	Dec 31, 2020
Q3 2020	38.3	+19.3	+102%	Sep 30, 2020
Q2 2020	28.2	+13.2	+87.4%	Jun 30, 2020
Q1 2020	25.9	+15.2	+144%	Mar 31, 2020
Q4 2019	23.8	+16.4	+219%	Dec 31, 2019
Q3 2019	19	+9.05	+91%	Sep 30, 2019
Q2 2019	15.1			Jun 30, 2019
Q1 2019	10.6			Mar 31, 2019
Q4 2018	7.46			Dec 31, 2018
Q3 2018	9.95			Sep 30, 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.